Quick answers
- What is Lyvispah?
- Lyvispah is a brand name of Baclofen, a prescription medicine. The FDA NDC Directory lists 4 Lyvispah products in 3 strengths and forms.
- Who makes Lyvispah?
- Strides Pharma Intl holds the FDA application for Lyvispah (NDA215422, approved November 22, 2021). 1 other company (repackagers or distributors) also list Lyvispah products.
- Is there a generic or store brand of Lyvispah?
- Other products of Baclofen are listed with the FDA, but none in exactly the same strength and form as a Lyvispah product.
- Has Lyvispah been recalled?
- No recall linked to Lyvispah products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lyvispah is
Each Lyvispah product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Baclofen · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| baclofen 10 mg granule (oral) | Lyvispah | None listed | DailyMed |
| baclofen 20 mg granule (oral) | Lyvispah | None listed | DailyMed |
| baclofen 5 mg granule (oral) | Lyvispah | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Baclofen →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA215422 | Strides Pharma Intl | November 22, 2021 | 4 |
Companies that list Lyvispah
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lyvispah products.
- Amneal Pharmaceuticals LLC3 products
- Anvi Pharmaceuticals Inc1 product
Recalls
No recall linked to Lyvispah products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.